photo walkheader_zpsd5bunpmi.png

Author Archives: pancreatica

Better Living Through Chemotherapy? Effects of treatment on pancreatic cancer patients

One of the observations that physicians often made when the standard of care treatment typically consisted of the chemotherapy drug agent of gemcitabine alone, was that many patients with pancreatic cancer (ductal adenocarcinoma of the pancreas) seemed to feel better after the initiation of treatment. In the past five years with the since widely deployed […]

Unfolding: Gemcitabine + Abraxane + Cisplatin for Stage 4 Pancreatic Cancer

Since the mid-1990s, teams affiliated with Dr. Daniel Von Hoff have ushered in two of the three key advances in the first-line treatment of advanced pancreatic cancer (ductal adenocarcinoma of the pancreas). This includes seminal work from a research institute affiliated with the University of Texas at San Antonio on the development of gemcitabine for […]

FOLFIRINOX vs. Gemcitabine plus Abraxane for Advanced Pancreatic Cancer

Every person is different; every situation is different; every cancer is different. So, the decision about which treatment is right for an individual patient with pancreatic cancer (ductal adenocarcinoma of the pancreas) by their health care team is highly complex. Here we present the work of published research that examines factors related to two of […]

Facebook
Facebook